B.Brilliant Revelation Comparision Study
University of Pennsylvania · with Siemens Corporation, Corporate Technology · NCT07067788
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- December 15, 2025
- Record last updated
- April 24, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is an observational study to evaluate the MAMMOMAT B.brilliant system. All diagnostic decisions are made by the treating radiologist based upon standard of care clinical imaging acquired on FDA approved devices
Being studied: Breast Imaging
Conditions: Breast Cancer Screening
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Participants will be ≥ 18 years of age.
- Participants will be females (sex assigned at birth).
- Participants will be presenting for clinical diagnostic mammography with suspicious calcifications or calcifications associated with other lesion types
- Participants must be informed of the investigational nature of this study and be willing to provide written informed consent and participate in this study in accordance with institutional and federal guidelines prior to study-specific procedures.
Exclusion Criteria
- Females who are breast-feeding will not be eligible for this study
- Pregnant women will not be included. All females of childbearing potential must attest that they are not pregnant.
- Inability to tolerate imaging procedures in the opinion of an investigator or treating physician.
- Any current medical condition, illness, or disorder, as assessed by medical record review and/or self-reported, that is considered by a physician investigator to be a condition that could compromise participant safety or successful participation in the study.
Recruiting US locations
Pennsylvania Hospital, Center for Breast Imaging
Philadelphia, PA 19107
Site contact: Jessica Nunez · 215-829-3712 · Jessica.Nunez@pennmedicine.upenn.edu
Study contacts (from the official record)
- Namaijah Faison Clinical Research Coordinator · 215-432-5000 · Namaijah.Faison@pennmedicine.upenn.edu
- Jessica Nunez Project Manager · 215-829-3712 · Jessica.Nunez@pennmedicine.upenn.edu
Similar studies in Pennsylvania
All healthy volunteers studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
Melissa Pugliano-Mauro
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Philadelphia, PA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Philadelphia, PA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Hershey, PA + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only